Now, listen closely. Apple and American Express? Dependable. Solid. Like your bubbe’s chicken soup. Kraft Heinz? Forget about it! That’s a mess. A total, unmitigated disaster. We’ll get to that later. Trust me, you’ll want to sit down for that one.
These transactions, in total, have gifted centralized exchanges 9.55K ETH-nearly $18.5M-a sum that could buy a small island or, more prosaically, a few months of survival in the crypto winter. Yet whether this is a feast or a famine remains to be seen.
The company, catering to those who mistake spending for living, enjoys a certain resilience. It is a haven for the affluent, a demographic that, while often lacking in taste, rarely lacks funds. This, of course, is the true security, not some fanciful notion of inherent value. One should always invest in the habits of others, not their virtues.
However, even with this minor setback, Lilly remains… expensive. Trading at 43 times its recent earnings, it’s priced as if it holds the secret to eternal youth – or at least, a very effective remedy for indigestion. The S&P 500, by comparison, is practically giving its earnings away. The question, then, is whether this premium is justified, or if a patient investor might be better served by waiting for a more… favorable moment.2
Pfizer currently distributes $0.43 per share quarterly, amounting to $1.72 annually. This means if their annual earnings per share fall below that figure, the payout ratio ventures into the realm of mathematical improbability. And recently, they have. Last month’s earnings report revealed a slight hiccup – a loss, actually – with earnings per share clocking in at a negative $0.29. This wasn’t due to any catastrophic failure of pharmaceutical innovation, mind you, but rather due to something called ‘asset impairment charges’ – roughly $4.4 billion worth. It’s a bit like the universe politely correcting Pfizer’s accounting, suggesting perhaps they’d overestimated the value of something. Full-year EPS landed at $1.36, a minor dip from the previous year’s $1.41. However, these impairment charges are non-cash items, which means they’re not actual money leaving the building, just a re-evaluation of what the building was worth in the first place. (It’s a bit like realizing your antique stamp collection is actually just a pile of colorful paper. Disappointing, but doesn’t immediately impact your ability to buy tea.)
Six months ago, it was all champagne and roses. Now? A mere 6% gain. The recent earnings report, perfectly adequate though it was, was met with a distinctly unimpressed shrug from the market. A 5% drop, you say? Honestly, it’s hardly the end of civilization. Still, one can’t help but wonder if the truly spectacular gains are already… accounted for.
This wasn’t a casual dip of the toe, mind you. This was a full-fledged plunge into the laundry business. As of the end of last year, nigh onto 90% of BDT Capital’s U.S. equity holdings was tied up in Alliance Laundry. A fella might wonder if they’re planning on opening the largest laundromat the world has ever seen.
Ferrari, then, ought to be a bellwether. A creature of desire, built on a foundation of wealth. And yet, the stock has fallen, a good twenty-one percent in the last turn of the seasons. A bear market, they call it – a chilling name for a simple truth: things go down as well as up. It’s a humbling thing, the market, and a good reminder that even the finest machine isn’t immune to the dust and the grit.
Apparently, oil decided to have a bit of a surge, topping $100 a barrel. Four years is a long time, honestly. Feels like yesterday I was meticulously tracking avocado toast expenditure. And just when I’d almost convinced myself I was financially responsible, the Bureau of Labor Statistics decided to drop a little bombshell: 92,000 jobs lost in February. Ninety-two thousand. It’s a number that just… sits there. Mocking my attempts at optimism.
They call it retail. A simple exchange. But Costco isn’t interested in the simplicity of profit margins. It isn’t about squeezing every last kopeck from the consumer. No, it’s a game of volume, a relentless pursuit of scale. The markup on goods? A meager 11%. A pittance. They don’t need to make money on the goods themselves. They’ve found a more reliable source, a steady drip of revenue from the huddled masses who pay for the privilege of entering the warehouse. Sixty-five dollars a year for the basic membership, a hundred and thirty for the ‘executive’ option—a small price to pay, it seems, for access to perceived savings. It’s a clever arrangement, a subtle extraction of wealth, masked by the promise of a bargain. The CEO speaks of being the lowest price, a ‘leading mantra.’ But mantras require faith, and faith rarely translates directly to shareholder value.